Drug Trial Radar · NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
534
Actual
Start
Nov 19, 2015
Primary completion
Oct 29, 2026
Study completion Oct 29, 2026
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Oct 5, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2/3, ROS1, or ALK gene fusion. Patients will be assigned to different baskets according to tumor type and gene fusion.
Conditions
- Breast Cancer
- Cholangiocarcinoma
- Colorectal Cancer
- Head and Neck Neoplasms
- Lymphoma, Large-Cell, Anaplastic
- Melanoma
- Neuroendocrine Tumors
- Non-Small Cell Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Papillary Thyroid Cancer
- Primary Brain Tumors
- Renal Cell Carcinoma
- Sarcomas
- Salivary Gland Cancers
- Adult Solid Tumor
Interventions
EntrectinibDrug
TrkA/B/C, ROS1, and ALK inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response RateTime frame: Approximately 24 months
Locations
115 sites in 16 countries. Site status is shown where the registry gives one.
Dignity Health St Joseph's Hospital and Medical Center
Phoenix, Arizona
Mayo Clinic
Phoenix, Arizona
City of Hope Cancer Center
Duarte, California
City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services
Duarte, California
Scripps Clinic
La Jolla, California
University of California San Diego Moores Cancer Center
La Jolla, California
Southern California Kaiser Permanente
Los Angeles, California
Univ Of California Irvine College Of Medicine
Orange, California
UCSF Mount Zion Medical Ctr
San Francisco, California
UCSF Mission Bay
San Francisco, California
Sarcoma Oncology Center
Santa Monica, California
Sarcoma Oncology Research Center LLC
Santa Monica, California
University of Colorado Cancer Center
Aurora, Colorado
Yale University
New Haven, Connecticut
Georgetown University Medical Center Lombardi Cancer Center
Washington D.C., District of Columbia
Florida Cancer Specialists - Sarasota
Sarasota, Florida
H. Lee Moffitt Cancer Center and Research Inst.
Tampa, Florida
Moffitt Cancer Center
Tampa, Florida
University Cancer & Blood Center, LLC
Athens, Georgia
Winship Cancer Institute
Atlanta, Georgia
Southeastern Regional Medical Center, Inc.
Newnan, Georgia
Northwestern University
Chicago, Illinois
Advocate Medical Group - Park Ridge, Luther Lane - Oncology
Park Ridge, Illinois
Midwestern Regional Medical Center
Zion, Illinois
Weinberg Cancer Institution at Franklin Square
Baltimore, Maryland
Massachusetts General Hosp CAR
Boston, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Dana Farber Cancer Institute
Boston, Massachusetts
Karmanos Cancer Center
Detroit, Michigan
Henry Ford Hospital
Detroit, Michigan
Regents of the University of Minnesota
Minneapolis, Minnesota
Washington University
St Louis, Missouri
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley
Las Vegas, Nevada
North Shore Hem Onc Associates
East Setauket, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Atrium Health Levine Cancer Institute
Charlotte, North Carolina
Levine Cancer Institute
Charlotte, North Carolina
Duke Cancer Institute
Durham, North Carolina
Ohio State University
Columbus, Ohio
Showing 40 of 115 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.